monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-CL interface
External Resource: Annotation
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| B [auth H] | Asparaginase_2 | e8tjfH1 | A: alpha arrays | X: RNase A-like | H: RNase A-like | T: RNase A-like | F: Asparaginase_2 | ECOD (v295.2) |
| D [auth B] | Asparaginase_2 | e8tjfB1 | A: alpha arrays | X: RNase A-like | H: RNase A-like | T: RNase A-like | F: Asparaginase_2 | ECOD (v295.2) |
| A [auth L] | Asparaginase_2 | e8tjfL1 | A: alpha arrays | X: RNase A-like | H: RNase A-like | T: RNase A-like | F: Asparaginase_2 | ECOD (v295.2) |
| C [auth A] | Asparaginase_2 | e8tjfA1 | A: alpha arrays | X: RNase A-like | H: RNase A-like | T: RNase A-like | F: Asparaginase_2 | ECOD (v295.2) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth H], D [auth B] | Timigutuzumab | ERBB2/CD340/HER2, TNFRSF9/CD137/4-1BB, CD3E, SIRPA | Therapeutic SAbDab (2026-11-13) |
| A [auth L], C [auth A] | Anvatabart | ERBB2/CD340/HER2, CD3E, SIRPA, TNFRSF9/CD137/4-1BB | Therapeutic SAbDab (2026-11-13) |